KPIX 5 spoke to Dr. Levi Garraway, chief medical officer at Genentech, about a pending clinical trial of Actemra, an anti-inflammatory medicine, as a possible treatment for COVID-19 patients.
(3-27-20)
Genentech to Begin Clinical Trial of Drug Treatment for COVID-19
Credit: CBS 5 SF KPIX
Duration: 01:54s
0 shares
1 views